About 100 reports

Fig ## PARADIGM SHIFT: RX TO CDX Fig ## ## ## ## ## ## ## ADVANCEMENTINTHERAPYAREAS ANALYSIS Sense and Response Predict and Act?

  • Molecular Diagnostic
  • North America
  • United States
  • World
  • Market Size
  • Market Definition

About High Density Multiplexed Diagnostic Assays A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes (dozens or more) in a single run/cycle of the assay. It is distinguished from procedures that measure one analyte at a time. The assay is one of the diagnostic procedures performed...

  • Molecular Diagnostic
  • World
  • Forecast
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.

The use of diagnostic techniques helps in early diagnosis of bacterial infection, autoimmune diseases, and cancer.

  • In Vitro Diagnostics
  • Molecular Diagnostic
  • Forecast
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.

Global Laboratory Reagents Industry LABORATORY REAGENTS MCP-## A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS ##.

  • Molecular Diagnostic
  • APAC
  • Japan
  • United States
  • World

Several vendors are focusing on developing companion diagnostic tests for cancer and autoimmune diseases.

  • Molecular Diagnostic
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • 2.4.8 IN-SITU HYBRIDIZATION CANCER DIAGNOSIS, CYTOLOGY, INFECTIOUS DISEASE MOLECULAR DIAGNOSTIC

PERKINELMER ASSAYS FOR AUTOIMMUNE DISEASE Source: PerkinElmer ## WWW. WINTERGREENRESEARCH. COM/ BLOG FIGURE ##.

  • Molecular Diagnostic
  • United States
  • Cepheid
  • PerkinElmer, Inc.
  • Quidel Corporation
  • 2.4.8 IN-SITU HYBRIDIZATION CANCER DIAGNOSIS, CYTOLOGY, INFECTIOUS DISEASE MOLECULAR DIAGNOSTIC

PERKINELMER ASSAYS FOR AUTOIMMUNE DISEASE Source: PerkinElmer ## WWW. WINTERGREENRESEARCH. COM/ BLOG FIGURE ##.

  • Molecular Diagnostic
  • United States
  • Cepheid
  • PerkinElmer, Inc.
  • Quidel Corporation

Autoimmune Diseases: Market Size and Forecast ##. ##. ##.

  • In Vitro Diagnostics
  • Molecular Diagnostic
  • World
  • 4 BIOCHIPS GLOBAL MARKET, BY TECHNOLOGY

WHEN KINASES BECOME OVER-ACTIVE, IT CAN CAUSE A RANGE OF LIFE THREATENING DISEASES SUCH AS CANCER AUTOIMMUNE DISORDERS, ALZHEIMER' S AND DIABETES.

  • Molecular Diagnostic
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • North America
  • United States
  • Alere Inc.
  • DiaSorin S.p.A.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • Brazil
  • South America
  • Alere Inc.
  • bioMerieux S.A.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • China
  • East Asia
  • Alere Inc.
  • DiaSorin S.p.A.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • East Asia
  • Japan
  • Alere Inc.
  • QIAGEN N.V.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • Germany
  • Western Europe
  • Alere Inc.
  • DiaSorin S.p.A.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • Northern Europe
  • United Kingdom
  • Alere Inc.
  • QIAGEN N.V.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • East Asia
  • South Korea
  • Alere Inc.
  • bioMerieux S.A.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • Eastern Europe
  • Russia
  • Alere Inc.
  • bioMerieux S.A.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • Southern Europe
  • Spain
  • Alere Inc.
  • bioMerieux S.A.
  • IMMUCOR: KEY TAKEAWAYS

The company also provides pharmacogenomic and autoimmune disease testing and research and genetic marker tests.

  • Molecular Diagnostic
  • CareDx, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Thermo Fisher Scientific, Inc.

In some cases, a tissue type test may be done to see whether a person has a chance for developing certain diseases that cause the body to attack its own cells, such as autoimmune diseases.

  • Molecular Diagnostic
  • World
  • Forecast
  • bioMerieux S.A.
  • Cepheid
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • Brazil
  • India
  • Russia
  • Forecast

TABLE ##. ##. ## SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) dPCR and qPCR has wide applications in the diagnosis of infectious diseases, oncology, autoimmune diseases, genetic diseases, drug testing, HIV/ AIDS and others.

  • Molecular Diagnostic
  • World
  • Forecast
  • Market Size
  • Roche Group

SOME EXAMPLES OF COMPLEX DISEASES INCLUDE ASTHMA, PARKINSON' S DISEASE, ALZHEIMER' S DISEASE, MULTIPLE SCLEROSIS, AUTOIMMUNE DISEASES, SCLERODERMA, KIDNEY DISEASES, AND OSTEOPOROSIS.

  • Molecular Diagnostic
  • North America
  • United States
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

FALSE POSITIVES ARE GENERALLY SEEN IN THE POPULATION WITH PREGNANCY, HIV, LYME DISEASE, PNEUMONIA, MALARIA, TUBERCULOSIS, SYSTEMIC LUPUS AND SOME OTHER AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • East Asia
  • Forecast
  • Market Segment
  • Market Size

In some cases, a tissue type test may be done to see whether a person has a chance for developing certain diseases that cause the body to attack its own cells, such as autoimmune diseases.

  • Molecular Diagnostic
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid

It also helps in identifying the cause of health disorders such as Alzheimer' s disease; Parkinson' s disease; autoimmune diseases such as scleroderma, multiple sclerosis, and connective tissue disease; osteoporosis; and asthma.

  • Molecular Diagnostic
  • World
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.

Clinical diagnostic segment includes products for diabetes monitoring, blood typing, blood virus testing, autoimmune and genetic disorder testing.

  • Chromatography
  • Genomics
  • Healthcare
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • 6.3.7 DIAGNOSTICS

DNA MICROARRAYS HAVE BEEN EXTENSIVELY USED FOR TRANSCRIPTIONAL PROFILING OF MANY AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • GE Healthcare Limited

CLINICAL DIAGNOSTIC SEGMENT INCLUDES PRODUCTS FOR DIABETES MONITORING, BLOOD TYPING, BLOOD VIRUS TESTING, AUTOIMMUNE AND GENETIC DISORDER TESTING.

  • Molecular Diagnostic
  • World
  • Market Size
  • CareDx, Inc.
  • Illumina, Inc.
  • MYRIAD GENETICS, INC.

THE PHENOMENA OCCUR IN EVERY INDIVIDUAL, BUT ARE AUGMENTED IN CERTAIN STATES, SUCH AS PREGNANCY, CANCER, AND AUTOIMMUNE DISEASES.

  • Molecular Diagnostic
  • World
  • Epigenomics AG
  • QIAGEN N.V.
  • Roche Group